BNET Industries
Millennium Pharmaceuticals Inc. (MLNM) is in the Pharma Industry
- Revenue
- Dec 31 2007
- $527.5M
- Profit
- Dec 31 2007
- $14.9M
- Market Cap
- May 08 2008
- $8.1B
Latest News and Analysis
New Analyst Reports for GILEAD SCIENCES INC, ISIS PHARMACEUTICALS INC, CURIS INC, and MILLENNIUM PHARMACEUTICALS INC
MaybachFinancial.com is one of the fastest growing independent and unbiased research firms in the world. Through our numerous partnerships with many of the top investment minds in the world, we provide research on companies making a move in the markets. Investors seeking genuine analyst opinions on their investments for GILEAD...
Takeda's Spree Peaks With Millennium Buy
The Japanese are coming! Well, to be exact, one Japanese drugmaker, Takeda Pharmaceutical, is coming. And the big question is whether its recent buying spree -- capped by its $8.8 billion acquisition of the biotech Millennium Pharmaceuticals announced today -- will leave it looking more like...
Zacks Bull and Bear of the Day Highlights: Millennium Pharmaceuticals, Embraer Air, Sohu.com and CACI International
CHICAGO -- Zacks Equity Research highlights Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) as the Bull of the Day and Embraer Air (NYSE: ERJ) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Sohu.com (Nasdaq: SOHU) and CACI International (Nasdaq: CACI). Full analysis of all these stocks...
Millennium Pharmaceuticals, Inc. Q4 2007 Earnings Call Transcript
Question-and-Answer SessionWe will take questions. Let me just start of the questions. Obviously there is a lot of excitement there regarding the complete response rate for VELCADE and uval [ph] filed a missing part of the review for frontline. Can you tell us about trends that you’re seeing so...
Millennium Pharmaceuticals 2008 Guidance Call Transcript
Question-and-Answer Session Operator Operator Instructions Our first question will come from Rachel McMinn with Cowen and Company. Rachel McMinn – Cowen and Company, LLC I wanted to better understand and I don’t know if you’re actually prepared to really talk about this but for the fourth...
Millennium Pharmaceuticals Q3 2007 Earnings Call Transcript
Question-and-Answer SessionOperator Operator Instructions. We will take our first question from Edward Tenthoff with Piper Jaffray. Edward Tenthoff - Piper Jaffray Hi Marsha. Congratulations on a very nice quarter. Deborah Dunsire Thanks. Marsha Fanucci Thank you. Edward Tenthoff - Piper Jaffray Looking into the U.S. market sales strength, how...
Zacks Buy List Highlights: Millennium Pharmaceuticals, Corn Products International, Baidu.com and Insight Enterprises
CHICAGO -- Zacks.com releases the latest list of Zacks Rank Buy Stocks. Everyday on Zacks.com, four stocks are selected based on how well they match the criteria for the four main schools of investing: Aggressive Growth, Growth & Income, Momentum and Value. The four Zacks Rank Buy stocks highlighted today...
Zacks Bull and Bear of the Day Highlights: Bayer AG, Millennium Pharmaceuticals, ExxonMobil and Becton, Dickinson
CHICAGO -- Zacks Equity Research highlights Bayer AG (NYSE: BAY) as the Bull of the Day and Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on ExxonMobil (NYSE: XOM) and Becton, Dickinson (NYSE: BDX). Full analysis of all four stocks...
Millennium Pharmaceuticals Q2 2007 Earnings Call Transcript
Question-and-Answer SessionOperator Yes, sir. We will take the first question from Chris Raymond with Robert Baird. Please go ahead, sir. Chris Raymond – Robert Baird Hello. Thanks. Thanks for taking my question. Just sort of a commercial question. I know...
Zacks Bull and Bear of the Day Highlights: Tenneco, Millennium Pharmaceuticals, DJO, Inc. and General Growth Properties
CHICAGO -- Zacks Equity Research highlights Tenneco, Inc. (NYSE: TEN) as the Bull of the Day and Millennium Pharmaceuticals (Nasdaq: MLNM) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on DJO, Inc. (NYSE: DJO) and General Growth Properties (NYSE: GGP). Full analysis of all four...
Millennium Pharmaceuticals Q1 2007 Earnings Call Transcript
Question-and-Answer SessionOperator Thank you Operator Instructions. Our first question will come from Phil Nadeau with Cowen and Company. Phil Nadeau - Cowen and Co. Good morning. Congratulations on the solid quarter and thanks for taking my questions. Deborah Dunsire Thank you. Phil Nadeau...
WPI to Feature Millennium Pharmaceuticals CEO Deborah Dunsire as its 2007 Commencement Speaker
To: EDUCATION EDITORSTo: EDUCATION EDITORS
Zacks Analyst Blog Highlights: Millennium Pharmaceuticals, Celgene, Merck and PetMed Express
CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM), Celgene (Nasdaq: CELG), Merck & Co....
Zacks Sell List Highlights: Bally Technologies, Polaris, Millennium Pharmaceuticals and Compuware
CHICAGO -- Zacks.com releases details on a group of stocks that are currently members of the exclusive Zacks #5 Rank List - Stocks to Sell Now. These stocks are currently rated as a Zacks Rank #5 Strong Sell: Bally Technologies Inc. (NYSE: BYI) and Polaris Industries Inc. (NYSE: PII). Further,...
Millennium Pharmaceuticals Q2 2006 Earnings Conference Call Transcript (MLNM)
Question-and-Answer SessionOperator [Operator Instructions]. We'll go first to Geoffrey Meacham at J.P. Morgan. Chris Demetropolis - JPMorgan Chase & Co Hi. Thanks for taking my question. Actually, this is Chris Demetropolis for Jeff. Just wondering if you could discuss what regimens you're seeing VELCADE usage in...
Schaeffer's Announces Posture Changes for American Express, Bausch & Lomb, Comcast, Millennium Pharmaceuticals, and Lowes Companies
CINCINNATI -- SchaeffersResearch.com today announced the following upgrades and downgrades according to its Scorecard ranking system.
Millennium Pharmaceuticals - President of Research & Development Interview
JOE KERNEN, CNBC ANCHOR: There has been more positive news in the fight against cancer coming out of ASCO. Big pharma and biotech presenting strong research results at the world`s largest oncology conference in Atlanta that gets more and more well-a JOE KERNEN, CNBC ANCHOR:...
Millennium Pharmaceuticals, Inc. Q1 2006 Earnings Conference Call Transcript (MLNM)
Earnings Call Excerpt Millennium Pharmaceuticals, Inc. MLNM Q1 2006 Earnings Conference Call April 27th 2006, 7:30 AM. Executives: Kyle Kuvalanka, Director, Investor and Corporate Communications Marsha Fanucci, Chief Financial Officer and SVP, Corporate Strategy Robert Tepper, President, R&D Deborah Dunsire, President...
ImmunoGen, Inc. Announces Extension of Technology Access Agreement by Millennium Pharmaceuticals, Inc
CAMBRIDGE, Mass. -- ImmunoGen, Inc. (Nasdaq: IMGN) today announced that Millennium Pharmaceuticals, Inc. has extended the agreement that provides Millennium with certain rights to test ImmunoGen's Tumor-Activated Prodrug TAP technology with antibodies to specific targets and to license the right to use the technology to develop products on the terms...
Millennium Pharmaceuticals Q4 2005 Earnings Conference Call Transcript (MLNM)
Earnings Call Excerpt Millennium Pharmaceuticals Inc. MLNM Q4 2005 Earnings Conference Call January 26th 2006, 8:30 PM. Executives: Dr. Deborah Dunsire, President and Chief Executive Officer Marsha Fanucci, Chief Financial Officer & Sr. VP Corporate Strategy Dr. Robert Tepper, President of Research...
- Next »
- page 1 of 8
- « Previous
Sort byClose
View by Content TypeClose
View Related Content by Tag Close
- VELCADE (29 results)
- Millennium (27 results)
- Patient (26 results)
- stock (25 results)
- Healthcare (13 results)
- Clinical Trial (12 results)
- FDA (11 results)
- (10 results)
- Federal Government (10 results)
- Government (10 results)
- MLN2704 (5 results)
- Nasdaq Stock Market Inc. (4 results)
- pharmaceutical company (4 results)
- Exxon Mobil Corp. (4 results)
- agreement (4 results)
- Home Depot Inc. (3 results)
- company (3 results)
- NVidia Corp. (3 results)
- Abbott Laboratories Inc. (3 results)
- Comcast Corp. (3 results)
- IBM Corp. (3 results)
- Schering-Plough Corp. (3 results)
- Qualcomm Inc. (3 results)
- Incorporated: 1993
- CEO: Dr. Deborah Dunsire M.D.
Millennium Pharmaceuticals is a biopharmaceutical company focused on discovering, developing and commercializing medicines to improve the lives of patients with cancer, inflammatory bowel diseases and other inflammatory diseases. Co.'s VELCADE® (bortezomib) product for Injection, is marketed for the treatment of patients with multiple myeloma who have received at least one prior therapy and for the treatment of Mantle Cell Lymphoma, or MCL, patients who have received at least one prior therapy. Co. distributes VELCADE in the U.S. through a sole-source open access distribution model where Co. sells directly to an independent third party who in turn distributes to the wholesaler base.
Key Competitors
Millennium Pharmaceuticals Inc. Company Info
Board of Directors
Mr. Kenneth E. Weg
Chairman
Dr. Jeffrey M. Leiden M.D., Ph
Mr. A. Grant Heidrich III
Vice-Chairman
Dr. Anthony H. Wild Ph.D.
Mr. Mark J. Levin
Dr. Charles J. Homcy M.D.
Dr. Raju S. Kucherlapati Ph.D.
Mr. Norman C. Selby
Dr. Deborah Dunsire M.D.
Mr. Robert F. Friel
Contact Information
40 Landsdowne Street
Cambridge, MA
617 679-7000
NAICS Code
Pharmaceutical Preparation Manufacturing: 325412
